GAI
OGN icon

General American Investors’s Organon & Co OGN Stock Holding History

General American Investors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,519
Closed -$742K – 73
2021
Q2 		$742K Buy
+24,519
New +$807K 0.06% 70

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

General American Investors's OGN Position: Q3 2021 in Review

General American Investors sold out of Organon & Co (OGN) in Q3 2021, closing a stake of 24,519 shares — an estimated $742K sold.

General American Investors first reported a position in OGN in Q2 2021 and held it in 1 quarter. The position peaked at $742K in Q2 2021. 928 funds tracked by Wall St. Rank hold OGN as of Q3 2021.

  • General American Investors reported no remaining Organon & Co position as of Q3 2021 after selling out during the quarter.
  • General American Investors sold 24,519 Organon & Co shares in Q3 2021, an estimated $742K.
  • General American Investors first reported a position in Organon & Co in Q2 2021 and held it in 1 quarter.
  • General American Investors's Organon & Co position peaked at $742K in Q2 2021.
  • 928 funds tracked by Wall St. Rank held Organon & Co as of Q3 2021.

Based on General American Investors's 13F filing for Q3 2021, filed 1 Nov 2021.